US News & World Report - Biotech Stocks Jonathan Gertler Posts, NewsJonathan Gertler, MDOctober 17, 2016
Pfizer To Acquire Medivation: From $1.00 TO $81.50 Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsSeptember 20, 2016M&A
Wall Street Journal Pro Equity: Healthcare Tech Trends News, Back Bay in the NewsBack Bay Life Science AdvisorsSeptember 20, 2016Healthtech
Investing News: Three Ways to Invest in Biotech Newsjonathan gertlerAugust 15, 2016Life Science Investment Banking
Life Science Mentoring: Back Bay Sponsors Tufts New England Case Competition Blog, NewsBack Bay Life Science AdvisorsAugust 12, 2016Mentoring, Startup
Mass Bio: Industry & Academia, Begin with the End in Mind Blog, Jonathan Gertler Posts, NewsBack Bay Life Science AdvisorsAugust 1, 2016Academic-Industry Partnering, Tech Transfer
The Future of Payment Reform: Looking to the CMMI for Hints Blog, NewsBack Bay Life Science AdvisorsJune 27, 2016Payors, Healthcare Delivery
Xconomy: Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case News, Back Bay in the NewsBack Bay Life Science AdvisorsJune 22, 2016Biotech IPO
Wall Street Journal Pro Capital: Health-Care VCs Emerge from Tech Investors’ Shadow NewsBack Bay Life Science AdvisorsMay 20, 2016VC, Life Science Investment Banking
Blog: Volatility Impacts Frequency of Option-Related Deals Blog, Greg Benning Posts, NewsInvestment Banking TeamMay 2, 2016Transactions, Biotech Deals
Blog: Issues Facing Specialty Pharmacies Blog, NewsBack Bay Life Science AdvisorsFebruary 28, 2016Specialty Pharma
JP Morgan Healthcare Conference 2015 Recap, 2016 Outlook Blog, Greg Benning Posts, NewsBack Bay Life Science AdvisorsJanuary 31, 2016Life Science Financing, Investing
